Can ultrasound spot breathing trouble in FSHD before It's too late?
NCT ID NCT06078852
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study follows 34 adults with FSHD over one year to see how their breathing muscles change. Researchers will use ultrasound to measure diaphragm thickness and movement, along with standard breathing tests. The goal is to find out if ultrasound can detect respiratory problems earlier and more accurately than current methods.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a non-invasive way to monitor breathing problems in FSHD, helping doctors detect changes earlier.
- What could go wrong
- This is a small, early-stage study with only 34 participants. It is not testing a treatment, so it will not directly improve health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 34 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2023
- Expected to finish
-
Jul 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of FSHD, genetically confirmed. * Adult patients (18 years or older) * Signature from the patient on the written informed consent document Exclusion Criteria: \- Medical history of neck and mediastinal trauma and/or surgery and/or radiation therapy (e.g. total thyroidectomy, mastectomy) with evidence of phrenic nerve injury.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Facioscapulohumeral muscular dystrophy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Fondazione Policlinico Gemelli IRCCS
RECRUITINGRoma, 00168, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a national patient registry unlock the secrets of a rare muscle disease?
- Can MRI reveal the hidden progression of muscular dystrophy?
- Personalized exercise program aims to boost mobility in rare muscle diseases
- New hope for FSHD: Long-Term drug safety trial underway
- New hope for FSHD: experimental drug AOC 1020 completes early testing
- New tools aim to speed up FSHD drug trials